Table 1.
Demographic and biological characteristics of colorectal cancer.
| Factor | N(%) |
|---|---|
| Age | |
| ≤25 | 37(18.4) |
| 26–50 | 95(47.3) |
| 51–75 | 63(31.3) |
| ≥75 | 6(3.0) |
| Tumour stage | |
| T1 | 2(1.1) |
| T2 | 50(27.5) |
| T3 | 89(48.9) |
| T4 | 15(8.2) |
| Lymph node stage | |
| N0 | 41(22.5) |
| N1 | 49(26.9) |
| N2 | 9(4.9) |
| Metastatic status | |
| M0 | 169 (92.4) |
| M1 | 14 (7.7) |
| Grade | |
| Well differentiated | 59(29.6) |
| Moderately differentiated | 97(48.7) |
| Poorly differentiated | 43(21.6) |
| Histological types | |
| Adenocarcinoma | 123(61.5) |
| Mucinous adenocarcinoma | 50(25.0) |
| Micro-papillary carcinoma | 14(7.0) |
| Signet ring cell carcinoma | 7(1.5) |
| Other types | 6(3.0) |
| Biological markers | |
| Ki67 Positive | 165(82.1) |
| CDX2 Positive | 171(85.1) |
| ER positive | 6(3.0) |
| PR positive | 5(2.5) |
| HER2 positive | 9(4.5) |
| EGFR positive | 17(8.5) |
| Bcl2 positive | 5(2.5) |
| P53 positive | 87(43.3) |
| CK20 positive | 199(99.0) |
| CEA positive | 198(98.5) |
| E-Cadherin positive | 199(99.0) |
| PDL-1 positive | 29(14.4) |
| VEGF positive | 11(5.5) |